Andere talen Jointown Pharmaceutical Group Co., Ltd

Aandelen

600998

CNE100000W45

slotkoers Shanghai S.E. Andere beurzen 00:00:00 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,2 ^CNY	-3,53%		-1,68%	+16,98%

08/04	Jointown Pharmaceutical richt gezamenlijk AI-laboratorium op met Peking University's Wuhan Campus	MT
2023	Jointown Pharmaceutical Group Co., Ltd rapporteert resultaten voor de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus	08/04
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd	27-10-23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets	05-07-23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24-04-23
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	13-01-23
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	04-01-23
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction	13-12-22
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	27-10-22
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.	25-10-22
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	24-10-22
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	11-10-22
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding	25-08-22
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	11-07-22
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	02-07-22
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.	09-06-22
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.	26-04-22
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.	26-04-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jointown Pharmaceutical Group Co., Ltd

Aandelen

600998

CNE100000W45

Andere talen

Filters